Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Satellite constellations could obscure most space telescope observations by late 2030s: 'That part of the image will be forever lost' - 2Starship success, a private moon landing and more: The top 10 spaceflight stories of 2025
- 3Insane Realities That Will Make You Reconsider How you might interpret History
- 4AI is making spacecraft propulsion more efficient – and could even lead to nuclear-powered rockets
- 5Palestinians forced from West Bank refugee camps left in limbo as Israeli demolitions go on
- World leaders, rights groups react to COP30 climate deal
- What to know about cheese voluntarily recalled in 20 states
- Gen Z workplace stereotypes were TV’s favorite punchline in 2025
- The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
- The Ascent of Robots: Occupations That Man-made brainpower Might Dispense with
- This Tiny Bright Yellow Frog Is One of the Most Toxic Animals on Earth
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- Israeli Chief of Staff declares new border with Gaza Strip
- Gaza Strip sees flooding after heavy rainfall
